General Information of Drug Off-Target (DOT) (ID: OT0963JJ)

DOT Name Charged multivesicular body protein 3 (CHMP3)
Synonyms Chromatin-modifying protein 3; Neuroendocrine differentiation factor; Vacuolar protein sorting-associated protein 24; hVps24
Gene Name CHMP3
Related Disease
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Herpes simplex infection ( )
Lung neoplasm ( )
Polyarteritis nodosa ( )
Triple negative breast cancer ( )
Vasculitis due to ADA2 deficiency ( )
UniProt ID
CHMP3_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2GD5; 2XZE; 3FRT; 3FRV; 7ZCG; 7ZCH
Pfam ID
PF03357
Sequence
MGLFGKTQEKPPKELVNEWSLKIRKEMRVVDRQIRDIQREEEKVKRSVKDAAKKGQKDVC
IVLAKEMIRSRKAVSKLYASKAHMNSVLMGMKNQLAVLRVAGSLQKSTEVMKAMQSLVKI
PEIQATMRELSKEMMKAGIIEEMLEDTFESMDDQEEMEEEAEMEIDRILFEITAGALGKA
PSKVTDALPEPEPPGAMAASEDEEEEEEALEAMQSRLATLRS
Function
Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Selectively binds to phosphatidylinositol 3,5-bisphosphate PtdIns(3,5)P2 and PtdIns(3,4)P2 in preference to other phosphoinositides tested. Involved in late stages of cytokinesis. Plays a role in endosomal sorting/trafficking of EGF receptor. Isoform 2 prevents stress-mediated cell death and accumulation of reactive oxygen species when expressed in yeast cells.
Tissue Specificity Widely expressed. Expressed in heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.
KEGG Pathway
Endocytosis (hsa04144 )
Necroptosis (hsa04217 )
Reactome Pathway
Macroautophagy (R-HSA-1632852 )
Pyroptosis (R-HSA-5620971 )
Endosomal Sorting Complex Required For Transport (ESCRT) (R-HSA-917729 )
HCMV Late Events (R-HSA-9610379 )
Late endosomal microautophagy (R-HSA-9615710 )
Sealing of the nuclear envelope (NE) by ESCRT-III (R-HSA-9668328 )
Translation of Replicase and Assembly of the Replication Transcription Complex (R-HSA-9679504 )
Translation of Replicase and Assembly of the Replication Transcription Complex (R-HSA-9694676 )
Budding and maturation of HIV virion (R-HSA-162588 )

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Advanced cancer DISAT1Z9 Strong Altered Expression [1]
Breast cancer DIS7DPX1 Strong Altered Expression [1]
Breast carcinoma DIS2UE88 Strong Altered Expression [1]
Herpes simplex infection DISL1SAV Strong Altered Expression [2]
Lung neoplasm DISVARNB Strong Biomarker [3]
Polyarteritis nodosa DISRQ5X8 Strong Altered Expression [1]
Triple negative breast cancer DISAMG6N Strong Altered Expression [1]
Vasculitis due to ADA2 deficiency DIS1UHPY Strong Altered Expression [1]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Charged multivesicular body protein 3 (CHMP3). [4]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Charged multivesicular body protein 3 (CHMP3). [5]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Charged multivesicular body protein 3 (CHMP3). [6]
Estradiol DMUNTE3 Approved Estradiol increases the expression of Charged multivesicular body protein 3 (CHMP3). [7]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of Charged multivesicular body protein 3 (CHMP3). [8]
Trichostatin A DM9C8NX Investigative Trichostatin A increases the expression of Charged multivesicular body protein 3 (CHMP3). [11]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Charged multivesicular body protein 3 (CHMP3). [9]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the methylation of Charged multivesicular body protein 3 (CHMP3). [10]
------------------------------------------------------------------------------------

References

1 miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.J Cell Physiol. 2020 Mar;235(3):2825-2835. doi: 10.1002/jcp.29188. Epub 2019 Sep 20.
2 Intracellular trafficking and maturation of herpes simplex virus type 1 gB and virus egress require functional biogenesis of multivesicular bodies.J Virol. 2007 Oct;81(20):11468-78. doi: 10.1128/JVI.01364-07. Epub 2007 Aug 8.
3 Neuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1.Oncogene. 2006 Mar 23;25(13):1943-54. doi: 10.1038/sj.onc.1209213.
4 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
5 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
6 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
7 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
8 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
9 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
10 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
11 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.